← SynDRA
Acetylcysteine amide
SynDRA canonical compound SYN1973524 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PSEN2 |
| Mechanism of action | antioxidant |
| Indication | parkinson's disease |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- N-Acetylcysteine amide
- (R)-2-acetamido-3-mercaptopropanamide
- Nac amide
- N-Acetyl-L-cysteinamide
- NACA
- N-Acetyl-L-cysteine amide
- acetylcysteinamide
- N-Acetyl-cysteine-amide
- Propanamide, 2-(acetylamino)-3-mercapto-, (2R)-
- MFCD01696115
- (2R)-2-acetamido-3-sulfanylpropanamide
- 4N69717RKW
- Propanamide, 2-(acetylamino)-3-mercapto-, (R)-
- (2R)-2-(Acetylamino)-3-mercaptopropanamide;
- UNII-4N69717RKW
- N-Acetylcysteine amide [WHO-DD]
- Ac-Cys-NH2
- N~2~-Acetyl-L-cysteinamide
- N-acetylcysteine amide;(R)-2-Acetamido-3-mercaptopropanamide
- SCHEMBL377413
- orb1301727
- orb1966049
- CHEBI:231847
- UJCHIZDEQZMODR-BYPYZUCNSA-N
- HMS3886B05
- NBA52057
- s5804
- AKOS006373417
- (2R)-2-acetamido-3-sulfanyl-propanamide
- DA-55966
- N-acetylcysteine amide, >=98% (HPLC)
- HY-110256
- CS-0033121
- T5518
- F826996
- Acetylcysteinamide
- N-乙酰-L-胱氨酸
- アセチルシステインアミド
- N-乙酰半胱氨酸
Look up Acetylcysteine amide in the interactive SynDRA portal →